Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. There is growing evidence that molecularchaperones, many of which are heat shock proteins HSPs, are involved in CVD pathogenesis. In this review we focus on HSP60,the human mitochondrial chaperone that also displays extramitochondrial and extracellular functions. HSP60 is typically cytoprotectivebut a number of stress conditions determine its conversion to a potentially toxic molecule for cells and tissues. We present illustrative examplesof specific subtypes of CVD where HSP60 is implicated in the initiation and/or progression of disease. The data not only indicatea pathogenic role for HSP60 but also its potential as a biomarker with applications for diagnosis, assessing prognosis and response totreatment, as well as for preventing and treating CVD. © 2011 Bentham Science Publishers.

Rizzo, M., Macario, A., de Macario, E.C., Gouni-Berthold, I., Berthold, H.K., Rini, G.B., et al. (2011). Heat Shock Protein-60 and Risk for Cardiovascular Disease. CURRENT PHARMACEUTICAL DESIGN, 17(33), 3662-3668 [10.2174/138161211798220981].

Heat Shock Protein-60 and Risk for Cardiovascular Disease.

RIZZO, Manfredi;ZUMMO, Giovanni;CAPPELLO, Francesco;RINI, Giovam Battista
2011-01-01

Abstract

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. There is growing evidence that molecularchaperones, many of which are heat shock proteins HSPs, are involved in CVD pathogenesis. In this review we focus on HSP60,the human mitochondrial chaperone that also displays extramitochondrial and extracellular functions. HSP60 is typically cytoprotectivebut a number of stress conditions determine its conversion to a potentially toxic molecule for cells and tissues. We present illustrative examplesof specific subtypes of CVD where HSP60 is implicated in the initiation and/or progression of disease. The data not only indicatea pathogenic role for HSP60 but also its potential as a biomarker with applications for diagnosis, assessing prognosis and response totreatment, as well as for preventing and treating CVD. © 2011 Bentham Science Publishers.
2011
Rizzo, M., Macario, A., de Macario, E.C., Gouni-Berthold, I., Berthold, H.K., Rini, G.B., et al. (2011). Heat Shock Protein-60 and Risk for Cardiovascular Disease. CURRENT PHARMACEUTICAL DESIGN, 17(33), 3662-3668 [10.2174/138161211798220981].
File in questo prodotto:
File Dimensione Formato  
99 Curr Pharm Des 2011.pdf

Solo gestori archvio

Dimensione 7.19 MB
Formato Adobe PDF
7.19 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
RW 20. Rizzo et al., CPD 2011.pdf

accesso aperto

Dimensione 404.76 kB
Formato Adobe PDF
404.76 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/77607
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 35
social impact